tiprankstipranks
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874)
:0874
Hong Kong Market
0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
RESEARCH TOOLSreports

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Financial Statements

0 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Financial Overview

Guangzhou Baiyunshan Pharmaceutical Holdings Company's market cap is currently HK$40.60B. The company's EPS TTM is HK$-0.221; its P/E ratio is 8.90; and it has a dividend yield of 7.15%. Guangzhou Baiyunshan Pharmaceutical Holdings Company is scheduled to report earnings on March 20, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 75.44B¥ 74.99B¥ 75.52B¥ 70.79B¥ 69.01B
Gross Profit¥ 11.45B¥ 12.52B¥ 14.19B¥ 13.28B¥ 13.23B
Operating Income¥ 3.02B¥ 3.60B¥ 5.12B¥ 5.07B¥ 4.79B
EBITDA¥ 3.95B¥ 4.90B¥ 6.49B¥ 6.22B¥ 5.82B
Net Income¥ 2.91B¥ 2.84B¥ 4.06B¥ 3.97B¥ 3.72B
Balance Sheet
Cash & Short-Term Investments¥ 23.81B¥ 22.72B¥ 21.31B¥ 22.56B¥ 22.38B
Total Assets¥ 84.55B¥ 81.68B¥ 78.59B¥ 74.67B¥ 66.12B
Total Debt¥ 20.70B¥ 12.37B¥ 11.70B¥ 11.43B¥ 9.92B
Net Debt¥ 5.75B¥ -5.90B¥ -9.61B¥ -11.07B¥ -12.45B
Total Liabilities¥ 43.40B¥ 43.91B¥ 41.91B¥ 41.03B¥ 34.79B
Stockholders' Equity¥ 37.80B¥ 35.90B¥ 34.92B¥ 32.07B¥ 29.06B
Cash Flow
Free Cash Flow¥ -954.34M¥ 2.31B¥ 2.48B¥ 5.62B¥ 4.42B
Operating Cash Flow¥ 253.50M¥ 3.44B¥ 4.10B¥ 7.00B¥ 5.67B
Investing Cash Flow¥ -3.81B¥ -5.96B¥ -3.11B¥ -7.25B¥ -931.57M
Financing Cash Flow¥ -98.13M¥ -1.01B¥ -1.98B¥ 45.95M¥ -1.49B
Currency in CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Company Earnings and Revenue History

Income Statement >

Guangzhou Baiyunshan Pharmaceutical Holdings Company Debt to Assets

Balance Sheet >

Guangzhou Baiyunshan Pharmaceutical Holdings Company Cash Flow

Cash Flow >

Guangzhou Baiyunshan Pharmaceutical Holdings Company Forecast EPS vs Actual EPS

Earnings >